Literature DB >> 24557080

Efficacy of an out-patient pain management programme for people with joint hypermobility syndrome.

Anisur Rahman1, Clare Daniel, Rodney Grahame.   

Abstract

Joint hypermobility syndrome (JHS) is common in patients presenting to rheumatologists and can cause a range of symptoms leading to physical and psychological distress. Chronic musculoskeletal pain in patients with JHS often responds poorly to analgesics, and a pain management approach may be helpful. Since patients with JHS often have beliefs and experiences different to those of other chronic pain patients, they could fare better in JHS-specific programmes. Here, we report on the outcomes of patients in a JHS cognitive behavioural pain management programme. Patients fulfilling the Brighton criteria for JHS, who had suffered pain for at least 3 months, were assessed by a psychologist and physiotherapist for suitability for this programme. Those accepted took part in a programme of 8 days spread over 6 weeks, delivered by a multidisciplinary team and incorporating a cognitive behavioural approach. Outcomes were assessed at baseline, 1- and 5-month post-programme using validated outcome measures. Outcome measures at baseline and 1-month were available for 87 patients (96 % female, mean age 35 years). There were significant improvements in self-efficacy, pain catastrophising, depression, anxiety, frustration, impact of pain and average pain intensity (all P < 0.001). Although by 5 months all these outcomes had regressed towards pre-programme levels there remained significant improvements compared to baseline in all except average pain intensity. This open study shows that patients with JHS experienced significant benefits after attending a JHS-specific pain management programme, which were still evident 5 months later. Longer-term controlled studies are required.

Entities:  

Mesh:

Year:  2014        PMID: 24557080     DOI: 10.1007/s10067-014-2539-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).

Authors:  R Grahame; H A Bird; A Child
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

2.  Hypermobility: an important but often neglected area within rheumatology.

Authors:  Rodney Grahame
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-02

Review 3.  Can we identify how programmes aimed at promoting self-management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs.

Authors:  Clare L Miles; Tamar Pincus; Dawn Carnes; Kate E Homer; Stephanie J C Taylor; Stephen A Bremner; Anisur Rahman; Martin Underwood
Journal:  Eur J Pain       Date:  2011-02-26       Impact factor: 3.931

4.  Pain in ehlers-danlos syndrome is common, severe, and associated with functional impairment.

Authors:  Nicol C Voermans; Hans Knoop; Gijs Bleijenberg; Baziel G van Engelen
Journal:  J Pain Symptom Manage       Date:  2010-06-25       Impact factor: 3.612

5.  The pain self-efficacy questionnaire: Taking pain into account.

Authors:  Michael K Nicholas
Journal:  Eur J Pain       Date:  2006-01-30       Impact factor: 3.931

6.  Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis.

Authors:  Lies Rombaut; Fransiska Malfait; Anne De Paepe; Steven Rimbaut; Gust Verbruggen; Inge De Wandele; Patrick Calders
Journal:  Arthritis Rheum       Date:  2011-07

7.  The development and testing of the depression, anxiety, and positive outlook scale (DAPOS).

Authors:  Tamar Pincus; Amanda C de C Williams; Steven Vogel; Andy Field
Journal:  Pain       Date:  2004-05       Impact factor: 6.961

8.  Attrition from a pain management programme.

Authors:  G M Coughlan; K L Ridout; A C Williams; P H Richardson
Journal:  Br J Clin Psychol       Date:  1995-09

Review 9.  Psychological therapies for the management of chronic pain (excluding headache) in adults.

Authors:  Amanda C de C Williams; Christopher Eccleston; Stephen Morley
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

10.  The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome).

Authors:  Brad T Tinkle; Howard A Bird; Rodney Grahame; Mark Lavallee; Howard P Levy; David Sillence
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

View more
  4 in total

1.  How do people with chronically painful joint hypermobility syndrome make decisions about activity?

Authors:  Anne Schmidt; Kelley Corcoran; Rodney Grahame; Amanda C de C Williams
Journal:  Br J Pain       Date:  2015-08

Review 2.  Clinical Relevance of Joint Hypermobility and Its Impact on Musculoskeletal Pain and Bone Mass.

Authors:  Vito Guarnieri; Marco Castori
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

3.  Mind the gaps: therapists' experiences of managing symptomatic hypermobility in Scotland.

Authors:  Dervil M Dockrell; Kathryn M Berg; Stuart H Ralston
Journal:  Rheumatol Adv Pract       Date:  2021-07-21

4.  Feeling Good Despite EDS: The Effects of a 5-Week Online Positive Psychology Programme for Ehlers-Danlos-Syndromes Patients.

Authors:  Larissa Kalisch; Ilona Boniwell; Evgeny Osin; Carolina Baeza-Velasco
Journal:  J Contemp Psychother       Date:  2021-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.